Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Vortex 

Agios Pharmaceuticals Inc. diskutieren

Agios Pharmaceuticals Inc.

WKN: A1W2RM / Symbol: AGIO / Name: Agios / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /

30,60 €
3,38 %

5 0
5
0

Sell Agios Pharmaceuticals Inc.

Vortex 
0
Melden Teilen
01.10.19 Sell 17,15 %

Sell Agios Pharmaceuticals Inc.

Commando 
0
Melden Teilen
25.10.19 Sell 47,80 %
Einschätzung Sell
Rendite (%) 17,15 %
Kursziel
Veränderung
Endet am 03.12.19

Sell beendet

Vortex 
0
Melden Teilen
03.12.19
Einschätzung Sell
Rendite (%) 47,80 %
Kursziel
Veränderung
Endet am 28.12.19

Sell beendet

Commando 
0
Melden Teilen
28.12.19

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for AGIO provided by MarketBeat

StockNews.com 
0
Melden Teilen
10.03.23 Sell 38,61 %

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Ratings data for AGIO provided by MarketBeat

Cantor Fitzgerald 
0
Melden Teilen
08.02.24 Buy 37,84 %
Einschätzung Buy
Rendite (%) 23,39 %
Kursziel 38,99
Veränderung
Endet am 16.02.25

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target lowered by analysts at Royal Bank of Canada from $43.00 to $42.00. They now have an "outperform" rating on the stock.
Ratings data for AGIO provided by MarketBeat

Royal Bank of Canada 
0
Melden Teilen
16.02.24

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for AGIO provided by MarketBeat

Cantor Fitzgerald 
0
Melden Teilen
09.04.24 Buy 11,68 %
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

Cantor_Fitzgerald in Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "over...
16:30
Evercore_ISI in Franklin Resources Inc. diskutieren
Franklin Resources, Inc. (NYSE: BEN) had its price target...
16:30
Cantor_Fitzgerald in NXP Semiconductors NV diskutieren
NXP Semiconductors (NASDAQ: NXPI) had its "overweight" r...
16:30
Benchmark_Co_ in Omnicell Inc. diskutieren
Omnicell, Inc. (NASDAQ: OMCL) had its "buy" rating re-af...
16:30
Benchmark_Co_ in Criteo S.A. ADR diskutieren
Criteo S.A. (NASDAQ: CRTO) had its "buy" rating re-affir...
16:30
Benchmark_Co_ in Alliance Resource Partners diskutieren
Alliance Resource Partners, L.P. (NASDAQ: ARLP) had its ...
16:30
Barclays_PLC in Xcel Energy Inc. diskutieren
Xcel Energy Inc. (NASDAQ: XEL) had its price target raise...
16:30
Barclays_PLC in Discuss Valero Energy Corp.
Valero Energy Co. (NYSE: VLO) had its price target lowere...
16:30
Mehr anzeigen